Guizhou Yibai Pharmaceutical Co (SHSE:600594) EPS (Basic) : ¥-0.30 (TTM As of Sep. 2024)

View and export this data going back to 2004. Start your Free Trial

What is Guizhou Yibai Pharmaceutical Co EPS (Basic)?

Guizhou Yibai Pharmaceutical Co's basic earnings per share (Basic EPS) for the three months ended in Sep. 2024 was ¥-0.08. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Sep. 2024 was ¥-0.30.

Guizhou Yibai Pharmaceutical Co's EPS (Diluted) for the three months ended in Sep. 2024 was ¥-0.08. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Sep. 2024 was ¥-0.30.

Guizhou Yibai Pharmaceutical Co's EPS without NRI for the three months ended in Sep. 2024 was ¥-0.05. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Sep. 2024 was -0.19.

During the past 12 months, Guizhou Yibai Pharmaceutical Co's average EPS without NRIGrowth Rate was -452.80% per year. During the past 3 years, the average EPS without NRI Growth Rate was -29.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 13 years, Guizhou Yibai Pharmaceutical Co's highest 3-Year average EPS without NRI Growth Rate was 44.40% per year. The lowest was -34.60% per year. And the median was 12.40% per year.

Guizhou Yibai Pharmaceutical Co EPS (Basic) Historical Data

The historical data trend for Guizhou Yibai Pharmaceutical Co's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Guizhou Yibai Pharmaceutical Co EPS (Basic) Chart

Guizhou Yibai Pharmaceutical Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

EPS (Basic)

Get a 7-Day Free Trial

0.16

0.28

0.31

-0.55

0.13

Guizhou Yibai Pharmaceutical Co Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
EPS (Basic)	Get a 7-Day Free Trial															0.05	-0.08	-0.09	-0.05	-0.08

Guizhou Yibai Pharmaceutical Co EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

Guizhou Yibai Pharmaceutical Co's Basic EPS for the fiscal year that ended in Dec. 2023 is calculated as

Basic EPS (A: Dec. 2023 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(103.399	-	0)	/	789.306
	=	0.13

Guizhou Yibai Pharmaceutical Co's Basic EPS for the quarter that ended in Sep. 2024 is calculated as

Basic EPS (Q: Sep. 2024 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(-62.658	-	0)	/	781.825
	=	-0.08

EPS (Basic) for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥-0.30

Guizhou Yibai Pharmaceutical Co (SHSE:600594) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

Guizhou Yibai Pharmaceutical Co EPS (Basic) Related Terms

Thank you for viewing the detailed overview of Guizhou Yibai Pharmaceutical Co's EPS (Basic) provided by GuruFocus.com. Please click on the following links to see related term pages.

Guizhou Yibai Pharmaceutical Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Guizhou Yibai Pharmaceutical Co Ltd (SHSE:600594) » Definitions » EPS (Basic)

Traded in Other Exchanges

N/A

Address

No. 220-1 Baiyun Avenue, Guiyang, Guizhou, CHN, 550008

Website

http://www.gzcci.com

Guizhou Yibai Pharmaceutical Co Ltd engages in the research, development, production, and sale of pharmaceutical products in China. Its products include tumor, cardio-cerebral vascular, respiratory system, anti-rheumatic, digestive system, pediatric, gynecological, andrological, anti-infection, anti-inflammatory, analgesic, tonic, and other drugs.

Executives

Dou Qi Ling	Director
Gan Ning	Director
Lang Hong Ping	Director
Xia Xiao Hui	senior management
Dou Ya Qi	Director
Wang Zhi Wei	Director
Zhu Yue Xing	Director
Dai Yuan Fu	senior management
Zhang Sheng Gui	senior management
Feng Zhi Gang	senior management
Yue Wei	Director
Liu Hua	Supervisors
Ye Xiang Wu	Director
Jian Wei Guang	Director

Guizhou Yibai Pharmaceutical Co Headlines

No Headlines